In vivo CAR engineering for immunotherapy
Nature Reviews Immunology, Published online: 16 May 2025; doi:10.1038/s41577-025-01174-1In vivo chimeric antigen receptor (CAR) engineering has emerged as a promising off-the-shelf therapeutic approach for hard-to-treat diseases such a…